Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
ConclusionThis case highlights the possibility of vaccine-induced thrombotic thrombocytopenia occurrence by whole-virus coronavirus disease 2019 vaccines. Compared with vector-based vaccines, this phenomenon is rare for whole-virus vaccines. More studies on this type of vaccine regarding thrombotic thrombocytopenia should be considered.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Back Pain | Coronavirus | Covid Vaccine | COVID-19 | Gammagard Liquid | General Medicine | Laboratory Medicine | Pain | Privigen | Pulmonary Thromboembolism | Study | Thrombocytopenia | Vaccines